Malaria Journal

Table 2 Per protocol outcome of treatment with AL and AS–AQ

From: Monitoring of efficacy, tolerability and safety of artemether–lumefantrine and artesunate–amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Lambaréné, Gabon: an open-label clinical trial

Outcome	AL			AS–AQ
Outcome	n	%	[95% CI]	N	%	[95% CI]
PCR-uncorrected
ETF	0	0	[0–8]	0	0	[0–8]
LCF	7	15	[6–29]	2	4	[1–15]
LPF	3	7	[1–18]	3	7	[1–18]
ACPR	36	78	[64–89]	40	89	[76–96]
ETF	0	0	[0–10]	0	0	[0–8]
PCR-corrected
LCF	0	0	[0–10]	1	2	[0–13]
LPF	1	3	[0–14]	1	2	[0–13]
ACPR	36	97	[86–100]	40	95	[84–99]

ACPR adequate clinical and parasitological response, ETF early treatment failure, LCF late clinical treatment failure, LPF late parasitological treatment failure

Back to article page

ISSN: 1475-2875

Contact us

Submission enquiries: journalsubmissions@springernature.com